INTRODUCTION
Angiodysplasia is the most common vascular lesion of the GI tract (1) . The terms angiodysplasia, arteriovenous malformation, and vascular ectasia have been synonymously used to describe the same entity (2) . It is responsible for close to 6.0% of cases with lower GI bleeding (3) . However, epidemiological data on this very common reason of lower GI hemorrhage is limited. Therefore, we designed this study to determine the hospitalization rates of ADOI in the U.S. population, analyze trend in demographic variations, and outcomes, and evaluate its economic impact on the healthcare system.
METHODS

Source of Data
The NIS, designed by Agency for Healthcare Research and Quality (AHRQ), is the largest all-payer inpatient database in the U.S. Data are compiled yearly and contain discharge information from over 1200 hospitals located across 45 states in the U.S. The NIS was designed to approximate a 20% stratified sample of community hospitals in the country and provides sampling weights to calculate national estimates (4) . The NIS contains information included in a typical 
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Trends in Hospitalizations
The hospitalization rate increased significantly from 185 per 1 million U.S. population in 2001 to 867 per 1 million U.S. population in 2011 (369.1% increase; p <0.0001; Table 2 ). The rate of hospitalization for ADOI with hemorrhage increased from 125 to 513 per million U.S. population per year (309% increase; p <0.0001). Also, the rate of hospitalization for ADOI without hemorrhage increased from 59 to 354 per million U.S. population per year (497% increase; p <0.0001). The hospitalization rate increased significantly for all age groups (p <0.0001). The hospitalization rate was higher in White race throughout the study period. Although, the hospitalization rate per million population was higher in women compared to men every single year during the study period (Table 2) , the percent increase in hospitalizations was higher in men compared to women (405% versus 343%; p <0.0001). Midwest region witnessed the highest percent increase in hospitalization per million population and Northeast witnessed the lowest rate (404% vs 339%; p <0.0001). 
AHRQ Co-morbidities
As per our analysis, the most common diagnoses associated with ADOI hospitalizations were hypertension (53.5%), renal failure (33.1%), and diabetes mellitus (28%). Trends of several other comorbidities associated with ADOI also increased significantly, as depicted in Table 1 .
All-cause Inpatient Mortality
Overall in-hospital all-cause mortality associated with these hospitalizations was 2%. Unsurprisingly, the overall mortality rate for patients hospitalized with ADOI with hemorrhage was higher than those without hemorrhage (2.2% vs 1.6%) (Figure 3) . However, the mortality rate for ADOI with hemorrhage decreased from 2.3% in 2001 to 1.9% in 2011 (19.2% decrease; p <0.0001) whereas it increased from 1.5% to 2.3% for ADOI without hemorrhage during the study period (53% increase; p <0.0001) ( Table 3 ). The mortality rate was highest in ≥80-year age group at 2.5%. The mortality rate was higher in males (2.1%) than females (1.9%). Also, mortality rate was highest in West (2.4%) and hospitalizations paid by Medicaid (2.2%). There was no significant difference in mortality rate as far as bed size was concerned ( Table 3) . 
DISCUSSION
Our study reports important findings associated with ADOI over a 10-year period in the U.S. Angiodysplasia accounts for a large percentage of GI bleeding, however, as they are commonly asymptomatic and found during investigation of an unrelated issue, limited epidemiologic information is available on the subject (2). We found that the number of hospitalizations related to angiodysplasia, both with and without hemorrhage, significantly increased during the study period. Cost of care per hospitalization related to this diagnosis increased by a staggering $95 million dollars over the course of the study period.
The etiology of angiodysplasias is not fully understood. Recent theory suggests that the lesions are the result of dilated and tortuous veins in the submucosa due to chronic low-grade intermittent obstruction of submucosal veins (13) . This idea is supported by the finding that angiodysplasias are most commonly located in areas of the GI tract with of high wall tension including the cecum and gastric antrum. It is not surprising then that the majority of angiodysplasia are acquired with age (3). Consistent with previously published studies, most of the hospitalizations in our study were identified in the 65 to 74 year age group (14, 15) . Survival bias and other factors such as multiple comorbidities, must also be considered as possible explanations of this trend.
From our analysis of the comorbidity measures, we found that the most frequent co-existing conditions were hypertension, diabetes, and renal failure. Von Willebrand disease and aortic stenosis have also been linked to higher rates of angiodysplasia. However, it remains unclear if it is the incidence or just detection rates in these populations that are higher (16) . Patients who have bled from gastrointestinal angiodysplasia and aortic stenosis should be referred for an evaluation for aortic valve replacement (17) .
Since the clinical presentation of angiodysplasia displays considerable variation, ranging from asymptomatic occult blood loss to life threatening GI hemorrhage, it is often difficult to diagnose (2) . More recently, expanded use of capsule endoscopy, balloon-assisted enteroscopy and computed tomographic angiography have enabled care providers to improve their diagnostic capabilities (17, 20) . Several treatment options including endoscopic interventions, endovascular embolization and surgery including minimally invasive procedures exist (21) . Interestingly, biomarkers such as Ang-2 and TIE-2 may now be able to predict the presence of gastrointestinal angiodysplasia and predict targets for future therapies (17) . Hence, facilities with highly trained specialists utilizing more sophisticated equipment are often required for diagnosis and management. Therefore, it is not surprising that hospitalizations with ADOI were found to be greater in larger more urban centers.
Throughout the study period, more women than men were hospitalized with a diagnosis of ADOI. However, our analysis revealed a change in trends; the percent increase in hospitalizations during the study period was higher in men than women. Hospitalizations were also higher in the white population, with the highest percent increase in hospitalizations per million in the Midwest region. Hernandez et al recently published a study in which they found a large geographic variation in oral anticoagulation use for atrial fibrillation, with the highest rates in the Midwest region of the U.S (22) . Increased bleeding risk in this population might explain a portion of the percent increased rate of hospitalizations for ADOI in this region. Overall, in-hospital all-cause mortality associated with these hospitalizations was 2%. Not surprisingly, mortality rates were highest in the > 80-year age group. Although mortality rates were higher in those with ADOI with hemorrhage, the mortality rate for ADOI with hemorrhage decreased during the study period. We postulate this is the result of advancements in imaging and endoscopic techniques enhancing our ability to better detect and manage occult gastrointestinal bleeding through the GI tract. Additionally, studies have shown newer techniques such as capsule endoscopy and double-balloon enteroscopy have a high diagnostic yield and positive impact on management in patients aged 65-70 years or more (23, 25) . Endotherapy with argon plasma coagulation resolves recurrent bleeding episodes in 83% of patients with GI angiodysplasias (26) . In patients who fail (or are not suitable for) other interventions, treatment with thalidomide or octreotide can lead to a clinically meaningful response in 71.4% and 77% of patients respectively (2) .
This study found a significant increase in the cost of care for ADOI related hospitalizations from 2001 to 2011. Greater use of advanced diagnostic and therapeutic techniques may be a major factor driving up costs. Alternatively, improvements in coding accuracy may explain this rising trend.
Analysis of the NIS database permitted us to study a large population. Such analysis should decrease the inherent bias seen in studies that are confined to a single region or hospital (4). However; there are limitations when it comes to using this type of healthcare utilization database. Multiple factors such as coding inaccuracies, missing clinical information, and the lack of outpatient characteristics, increase the potential for both overestimating and underestimating a particular diagnosis.
For example, our analysis of the NIS database using the ICD-9 codes did not permit us to differentiate between new onset versus prior history of hospitalization for ADOI with bleeding. In addition, the NIS considers each hospitalization as a separate entry; therefore, it is not possible to separate a new case of ADOI from a readmission (7) . These factors could result in an overestimation in the number of cases. Conversely, as angiodysplasias are often the culprit behind occult bleeding, particularly in the non-hospitalized population, there is a risk that our analysis could underestimate the number of bleeds related to angiodysplasia each year. Also important to consider is the fact that the lack of detailed clinical information may result in misclassification of outcomes related to a diagnosis (27).
Using the NIS database, we were only able to examine in-hospital characteristics; as such, the study did not permit analysis of long-term follow up of patient outcomes. In addition, it did not permit us to study health care utilization in out-patient settings or emergency departments.
In conclusion, our analysis of hospitalization trends from 2001-2011, found a consistent increase in the number of hospitalizations associated with angiodysplasia of the intestine as well as the cost of associated care. Angiodysplasia is now recognized as a major cause of both occult and overt GI bleeding (28). We believe that increases in awareness of the condition, along with improved diagnostic and therapeutic techniques, may result in further improvements in mortality rates in the future. Whether this will reduce the economic burden will require further study, but could be favorably influenced by efforts to ensure early diagnosis and to make treatment available at more health care centers.
